Healthcare
PRODUCTS
-
In today’s complex clinical research landscape, sponsors and CROs face numerous challenges that can impact study timelines, costs, and data quality. The iMednet platform offers innovative solutions to address these critical issues.
-
Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.
They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.
Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.
-
This dosator is part of 3P innovation’s Pharma Equipment Discover Range, which fully replicates commercial dosator based powder dispensing, at a laboratory scale.
-
By combining purpose-built polymers and lipids, animal-origin-free reagents seamlessly blend into the AAV manufacturing process during transfection to dramatically increase AAV titers.
-
With a portfolio of over 5,000 recombinant proteins and an industry-leading, scale-up ready protein development platform, ACROBiosystems has accumulated over 10 years of experience in developing recombinant proteins.
WHITE PAPERS AND CASE STUDIES
-
What Is Healthcare Data Interoperability And Why Does It Matter For Clinical Research?
Explore how healthcare data interoperability can transform patient outcomes, streamline clinical research, and enhance efficiencies while addressing key challenges and global initiatives.
-
Leveraging Single-Use Solutions To Solve Working Cell Bank Challenges
Discover how custom manifolds enhance allogeneic therapy development from formulation to commercialization by improving process control, scalability, and efficiency.
-
Automated Evidence Generation For Regulatory-Grade RWD
Global regulatory agencies increasingly adopt Real-World Evidence, demanding higher data quality and automated AI-driven platforms to meet evolving standards and improve drug development pathways.
-
Democratize Batch Data Management For AAV Gene Therapies
Explore a biotechnology company's process of choosing a data management solution that offered centralized batch data management, allowing the company to streamline its CMO data delivery process.
-
Aseptic Process Design And Simulation Under Annex 1 Guidelines
Gain insight into how Annex 1 reshapes aseptic process validation, as well as into risk reduction by design and why isolators are redefining modern sterile manufacturing standards.
-
Providing Enhanced Manufacturing Data To Contracting Companies
The life sciences sector is projected to reach $220 billion by 2030. Examine the growth of CDMOs and CMOs, emphasizing the need for digitalization to meet client demands and regulatory standards.
-
Advances In Regulations For Viable Environmental Monitoring
Viable air monitoring is critical for environmental monitoring programs in pharmaceutical manufacturing. Explore current regulatory standards as well as the impact of the EU GMP Annex 1 revisions.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
2025 Safety And Regulatory Compliance Trends And Predictions
Explore the rapidly evolving regulatory landscape that pharmaceutical and biotech industries face as they integrate AI and advanced technologies into safety, compliance, and lifecycle management.
-
Handle Single-Use Technology Biopharma Waste: Data Sharing, Collaboration
Learn more about data sharing and collaboration to enable a better environmental impact of single-use technologies (SUTs) and quantifying the single-use plastic waste generated when manufacturing mAbs.
-
OPTICHECK Technology Built-In – Diagnostics, Verification, And Functional Safety With OPTIMASS Coriolis Mass Flow Meters
State-of-the-art measuring devices such as OPTIMASS Coriolis mass flow meters combine robust measuring principles and powerful electronics to produce a wide range of readings and device-specific data. OPTICHECK technology built-in leverages the features of the devices to translate their available comprehensive measuring system data into sophisticated diagnostics information for plant personnel.
-
How A Pharma Company Improved Yield By 1.5% In Just Three Months
A pharma company faced a 4% yield drop and variability at a manufacturing facility. Explore how they leveraged an AI-based platform to unify data, pinpoint inefficiencies, and enhance consistency in yields.
NEWS
-
AmpliTech Group Announces Innovative True 5G Technology Development2/20/2025
AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced, it is setting the record straight on what constitutes True 5G and how its revolutionary technology is paving the way for the future of wireless connectivity.
-
IFS To Acquire Softeon, Supercharging The Warehouse Management Systems Category12/17/2025
IFS, the leading provider of Industrial AI software, today announced that it has entered into a definitive agreement to acquire Softeon, a Gartner Visionary and leading provider of cloud-native Warehouse Management, Warehouse Execution and Distributed Order Management solutions.
-
HealthEx Launches Platform To Empower Patients With Real-Time Health Record Access In Collaboration With Industry Leaders8/12/2025
HealthEx today launched its platform to enable patients to access, retrieve, and share their health records in real time, leveraging Individual Access Services (IAS) under the federal TEFCA™ framework.
-
ActiGraph Accelerates Clinical Trial Modernization With Transformational Acquisition Of Biofourmis Life Science Business1/22/2025
ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry. The combined solution will create a market-leading, unified software and data ecosystem for the modernization of clinical research throughout the drug-product lifecycle and across therapeutic areas.
-
Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift8/11/2025
Crucial Data Solutions (CDS), provider of the industry’s only end-to-end eClinical platform available as a native mobile app, today announced that Leigh J. Mack, MD, PhD has rejoined the company as Chief Medical Officer. Dr. Mack, who previously served in this role from 2017 to 2021, brings renewed focus to aligning artificial intelligence (AI) with the future of regulatory compliance and clinical trial execution.